Molecular genetic analysis of Epstein-Barr virus Cp promoter function

Journal of Virology

Volumn 70, Issue 3, 1996, Pages 1695-1705

  Evans, Tracy J ^a   Farrell, Paul J ^a   Swaminathan, Sankar ^b,c  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; VIRUS RNA;

ARTICLE; DNA BINDING; EPSTEIN BARR VIRUS; GENE EXPRESSION REGULATION; GENE MUTATION; LYMPHOBLASTOID CELL; MOLECULAR GENETICS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION INITIATION; VIRUS GENOME; VIRUS RECOMBINANT;

EID: 0030061034     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.3.1695-1705.1996     Document Type: Article

References (67)

1. Baer, R., A. T. Bankier, M. D. Biggin, P. L. Deininger, P. J. Farrell, T. J. Gibson, G. Hatfull, G. S. Hudson, S. C. Satchwell, C. Seguin, et al. 1984. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature (London) 310:207-211.
2. Ben-Bassat, H., N. Goldblum. S. Mitrani, T. Goldblum, J. M. Yoffey, M. M. Cohen, Z. Bentwich, B. Ramot, E. Klein, and G. Klein. 1977. Establishment in continuous culture of a new type of lymphocyte from a "Burkitt like" malignant lymphoma (line D.G.-75). Int J. Cancer 19:27-33.
3. Bodescot, M., O. Brison, and M. Perricaudet. 1986. An Epstein-Barr virus transcription unit is at least 84 kilobases long Nucleic Acids Res. 14:2611-2620.
4. Bodescot, M., M. Perricaudet, and P. J. Farrell. 1987. A promoter for the highly spliced EBNA family of RNAs of Epstein-Barr virus. J. Virol. 61:3424-3430.
5. Cohen, J. I., and E. Kieff. 1991. An Epstein-Barr virus nuclear protein 2 domain essential for transformation is a direct transcriptional activator. J. Virol 65:5880-5885
6. Dou, S., X. Zeng, P. Cortes, H. Erdjnment-Bromage, P. Tempst, T. Honjo, and L. D. Vales. 1994. The recombination signal sequence-binding protein RBP-2N functions as a transcriptional repressor. Mol. Cell. Biol. 14:3310-3319.
7. Evans, T. J., M. G. Jacquemin, and P. J. Farrell. 1995. Efficient EBV superinfection of group I Burkitt's lymphoma cells distinguishes requirements for expression of the Cp viral promoter and can activate the EBV productive cycle. Virology 206:866-877.
8. Fabraeus, R., A. Jansson, A. Sjoblom, T. Nilsson, G. Klein, and L. Rymo. 1993 Cell phenotype-dependent control of Epstein-Barr virus latent membrane protein 1 gene regulatory sequences. Virology 195:71-80.
9. Farrell, P. J., G. J. Allan, F. Shanahan, K. H. Vousden, and T. Crook. 1991. p53 is frequently mutated in Burkitt's lymphoma cell Sines. EMBO J. 10:2879-2887
10. Feinberg, A. P., and B. Vogelstein. 1983. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity Anal. Biochem. 132:6-13.
11. Finke, J., M. Rowe, B. Kallin, I. Ernberg, A. Rosen, J. Dillner, and G. Klein. 1987 Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines. J. Virol 61:3870-3878.
12. Furukawa, T., M. Kawaichi. N. Matsunami, H. Ryo, Y. Nishida, and T. Honjo. 1991. The Drosophila RBP-J kappa gene encodes the binding protein for the immunoglobulin J kappa recombination signal sequence J. Biol. Chem. 266:23334-23340.
13. Goodbourn, S. 1995 Notch takes a short cut Nature (London) 377:288-289.
14. Grossman, S. R., E. Johannsen, X. Tong, K. Yalamanchili, and E. Kieff. 1994. The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein, Proc. Natl. Acad. Sci. USA 91:7568-7572.
15. Gunning, P., P. Ponte, H. Okayama, J. Engel, H. Blau, and L. Kedes. 1983 Isolation and characterization of full-length cDNA clones for human α-, β-, and γ-actin mRNAs: skeletal but not cytoplasmic actins have an aminoterminal cysteine that is subsequently removed. Mol. Cell. Biol 3:787-795.
16. Henkel, T., P. D. Ling, S. D. Hayward, and M. G. Peterson. 1994 Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa. Science 265:92-95.
17. Hinuma, Y., and J. Grace, Jr. 1967 Cloning of immunoglobulin-producing human leukemic and lymphoma cells in long-term cultures Proc Soc. Exp Biol. Med. 124:107-111.
18. Hsieh, J. J., and S. D. Hayward. 1995. Masking of the CBF1 RBPJ kappa transctiptional repression domain by Epstein-Barr virus EBNA2. Science 268:560-563
19. Hurley, E. A., L. D. Klaman, S. Agger, J. B. Lawrence, and D. A. Thorley-Lawson. 1991. The prototypical Epstein-Barr virus-transformed lymphoblastoid cell line IB4 is an unusual variant containing integrated but no episomal viral DNA. J. Virol 65:3958-3963
20. Jacquemin, M. G., A. J. Sinclair, F. Shanahan, and P. J. Farrell. 1993 Analysis of p53, Rb. pim-1 and glucocorueoid receptor in Burkitt's lymphoma cell lines. Colloq. INSERM 225:43-49.
21. Jin, X. W., and S. H. Speck. 1992. Identification of critical cis elements involved in mediating Epstein-Barr virus nuclear antigen 2-dependent activity of an enhancer located upstream of the viral Bam HI C promoter. J. Virol 66:2846-2852.
22. Johannsen, E., E. Koh, G. Mosialos, X. Tong, E. Kieff, and S. R. Grossman. 1995. Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by JK and PU.1. J. Virol. 69:253-262
23. Kempkes, B., D. Spitkovsky, P. Jansen-Durr, J. W. Ellwart, E. Kremmer, H. J. Delecluse, C. Rottenberger, G. W. Bornkamm, and W. Hammer-Schmidt. 1995. B-cell proliferation and induction of early G1-regulating proteins by Epstein-Barr virus mutants conditional for EBNA2 EMBO J. 14:88-96.
24. King, W., A. L. Thomas-Powell, N. Raab-Traub, M. Hawke, and E. Kieff. 1980 Epstein-Barr virus RNA. V Viral RNA in a restringently infected, growth-transformed cell line. J. Virol. 36:506-518
25. Knott, V., D. J. Rees, Z. Cheng, and G. G. Brownlee. 1988. Randomly picked cosmid clones overlap the pyrB and oriC gap in the physical map of the E. coli chromosome. Nucleic Acids Res. 16:2601-2612.
26. Kupfer, S. R., and W. C. Summers. 1990. Identification of a glueocorticoid-responsive element in Epstein-Barr virus. J. Virol. 64:1984-1990
27. 26a.Ling, P., and S. D. Hayward. Personal communication.
28. Ling, P. D., J. J.-D. Hsieh, I. K. Ruf, D. R. Rawlins, and S. D. Hayward. 1994 EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate CBF1 J. Virol. 68:5375-5383.
29. Ling, P. D., D. R. Rawlins, and S. D. Hayward. 1993. The Epstein-Barr virus immortalizing protein EDNA-2 is targeted to DNA by a cellular enhancer-binding protein. Proc. Natl. Acad. Sci. USA 90:9237-9241.
30. Matsunami, N., Y. Hamaguchi, Y. Yamamoto, K. Kuze, K. Kangawa, H. Matsuo, M. Kawaichi, and T. Honjo. 1989 A protein binding to ihe J kappa recombination sequence of immunoglobulin genes contains a sequence related to the integrase motif. Nature (London) 342:934-937.
31. Meitinger, C., L. J. Strobl, G. Marschall, G. W. Burnkamm, and U. Zimber-Strobl. 1994. Crucial sequences within the Epstein-Barr virus TP1 promoter for EBNA2-mediated transactivation and interaction of EBNA2 with its responsive element. J. Virol. 68:7497-7506.
32. Melton, D. A., P. A. Krieg, M. R. Rebagliati. T. Maniatis, K. Zinn, and M. R. Green. 1984. Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter Nucleic Acids Res. 12:7035-7056.
33. Miller, G., and M. Lipman. 1973. Release of infectious Epstein-Brrt virus by transformed marmoset leukocytes. Proc. Natl. Acad. Sci. USA 70:190-194
34. Miller, J. H. 1972. Experiments in molecular genetics, p. 352-355. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
35. Morgenstern, J. P., and H. Land. 1990. A series of mammalian expression vectors and characterisation of their expression of a reporter gene in stably and transiently transfected cells. Nucleic Acids Res. 18:1068.
36. Rabson, M., L. Gradoville, L. Heston, and G. Miller. 1982. Non-immortalizing P3J-HR-1 Epstein-Barr virus: a deletion mutant of its transforming parent. Jijoye J Virol. 44:834-844
37. Rooney, C. M., M. Brimmell, M. Buschle, G. Allan, P. J. Farrell, and J. L. Kolman. 1992 Host cell and EBNA-2 regulation of Epstein-Barr virus latent-cycle promoter activity in B lymphocytes. J. Virol. 66:496-504
38. Rowe, M., D. T. Rowe, C. D. Gregory, L. S. Young, P. J. Farrell H. Rupani, and A. B. Rickinson. 1987. Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells. EMBO J. 6:2743-2751.
39. Sakai, D. D., S. Helms, J. Carlstedt-Duke, J. A. Gustafsson, F. M. Rottman, and K. R. Yamamoto. 1988. Hormone-mediated repression: a negative glucocorticoid response element from the bovine prolactin gene. Genes Dev. 2:1144-1154.
40. Sample, J., L. Brooks, C. Sample, L. Young, M. Rowe. C. Gregory, A. Rickinson, and E. Kleff. 1991. Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site. Proc. Natl. Acad. Sci. USA 88:6343-6347.
41. Sample, J., M. Hummel, D. Braun, M. Birkenbach, and E. Kieff. 1986 Nucleotide sequences of mRNAs encoding Epstein-Barr virus nuclear proteins a probable transcriptional initiation site. Proc. Natl. Acad Sci. USA 83:5096-5100.
42. Sanger, F., S. Nicklen, and A. R, Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463-5467.
43. Schaefer, B. C., J. L. Strominger, and S. H. Speck. 1995. The Epstein-Barr virus Bam HI F promoter is an early lytic promoter: lack of correlation with EBNA 1 gene transcription in group 1 Burkitt's lymphoma cell lines. J. Virol. 69:5039-5047.
44. Schaefer, B. C., M. Woisetschlaeger, J. L. Strominger, and S. H. Speck. 1991. Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes Proc Natl. Acad Sci. USA 88:6550-6554.
45. Schuster, C., S. Chasserot-Golaz, G. Urier, G. Beck, and A. Sergeant. 1991. Evidence for a functional glucocorticoid responsive element in the Epstein-Barr virus genome. Mol. Endocrinol. 5:267-272.
46. Sinclair, A. J., M. Brimmell, and P. J. Farrell. 1992. Reciprocal antagonism of steroid hormones and BZLF1 in switch between Epstein-Barr virus latent and productive cycle gene expression J Virol. 66:70-77.
47. Sinclair, A. J., M. Brimmell, F. Shanahan, and P. J. Farrell. 1991. Pathways of activation of the Epstein-Barr virus productive cycle. J Virol. 65:2237-2244.
48. Sinclair, A. J., and P. J. Farrell. 1995. Host cell requirements for efficient infection of quiescent primary B lymphocytes by Epstein-Barr virus. J. Virol. 69:5461-5468.
49. Sinclair, A. J., M. G. Jacquemin, L. Brooks, F. Shanahan, M. Brimmell, M. Rowe. and P. J. Farrell. 1994. Reduced signal transduction through glucocorticoid receptor in Burkitt's lymphoma cell lines. Virology 199:339-353.
50. Smith, P. R., and B. E. Griffin. 1992. Transcription of the Epstein-Barr virus gene EBNA-1 from different promoters in nasopharyngeal carcinoma and B-lymphoblastoid cells. J. Virol. 66:706-714.
51. Speck, S. H., A. Pfitzner, and J. L. Strominger. 1986. An Epstein-Barr virus transcript from a latently infected, growth-transformed B-cell line encodes a highly repetitive polypeptide. Proc. Natl Acad Sci USA 83:9298-9302.
52. Sugclen, B., and N. Warren. 1989. A promoter of Epstein-Barr virus that can function during latent infection can be transactivated by EBNA-1, a viral protein required for viral DNA replication during latent infection. J. Virol. 63:2644-2649.
53. Sung, N. S., S. Kenney, D. Gutsch, and J. S. Pagano. 1991. EBNA-2 transactivates a lymphoid-specific enhancer in the Bam HI C promoter of Epstein-Barr virus. J. Virol. 65:2164-2169.
54. 52a. Swaminathan, S. Characterization of Epstein-Barr virus recombinants with deletions of the Bam HI C promoter. Virology, in press.
55. Swaminathan, S., R. Hesselton, J. Sullivan, and E. Kieff. 1993. Epstein-Barr virus recombinants with specifically mutated BCRF1 genes. J. Virol. 67:7406-7413.
56. Swaminathan, S., B. Tomkinson, and E. Kieff. 1991 Recombinant Epstein-Barr virus with small RNA (EBER) genes deleted transforms lymphocytes and replicates in vitro Proc. Natl. Acad. Sci. USA 88:1546-1550.
57. Tierney, R. J., N. Steven, L. S. Young, and A. B. Rickinson. 1994. Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. J. Virol. 68:7374-7385.
58. Tun, T., Y. Hamaguchi, N. Matsunami, T. Furukawa, T. Honjo, and M. Kawaichi. 1994. Recognition sequence of a highly conserved DNA binding protein RBP-J kappa. Nucleic Acids Res. 22:965-971.
59. van-Santen, V., A. Cheung, M. Hummel, and E. Kieff. 1983. RNA encoded by the IR1-U2 region of Epstein-Barr virus DNA in latently infected, growth-transformed cells. J. Virol. 46:424-133.
60. Walls, D., and F. Cannon. 1988. The expression of novel antigens from the Epstein-Barr virus large internal repeat. EMBO J. 7:1191-1196.
61. Walls, D., and M. Perricaudet. 1991. Novel downstream elements upregulate transcription initiated from an Epstein-Barr virus latent promoter. EMBO J. 10:143-151.
62. Waltzer, L., F. Logeat, C. Brou, A. Israel, A. Sergeant, and E. Manet. 1994. The human J kappa recombination signal sequence binding protein (RBP-J kappa) targets the Epstein-Barr virus EBNA2 protein to its DNA responsive elements. EMBO J 13:5633-5638.
63. Wang, F., L. Petti, D. Braun, S. Seung, and E. Kieff. 1987 A bicistronic Epstein-Barr virus mRNA encodes two nuclear proteins in latently infected, growth-transformed lymphocytes. J. Virol. 61:945-954.
64. Woisetschlaeger, M., X. W. Jin, C. N. Yandava, L. A. Furmanski, J. L. Strominger, and S. H. Speck. 1991 Role for the Epstein-Barr virus nuclear antigen 2 in viral promoter switching during initial stages of infection. Proc. Natl. Acad. Sci. USA 88:3942-3946.
65. Woisetschlaeger, M., J. L. Strominger, and S. H. Speck. 1989. Mutually exclusive use of viral promoters in Epstein-Barr virus latently infected lymphocytes Proc. Natl Acad. Sci USA 86:6498-6502.
66. Woisetschlaeger, M., C. N. Yandava, L. A. Furmanski, J. L. Strominger, and S. H. Speck. 1990. Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes. Proc. Natl. Acad. Sci. USA 87:1725-1729.
67. Yandava, C. N., and S. H. Speck. 1992. Characterization of the deletion and rearrangement in the Bam HI C region of the X50-7 Epstein-Barr virus genome, a mutant viral strain which exhibits constitutive Bam HI W promoter activity. J. Virol. 66:5646-5650.